Prolactin in autoimmune diseases

Proceedings of the Society for Experimental Biology and Medicine

Volumn 217, Issue 4, 1998, Pages 408-419

  Neidhart, M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; PROLACTIN;

ADAPTATION; ARTHRITIS; AUTOIMMUNITY; CELL PROLIFERATION; HYPERPROLACTINEMIA; IMMUNE SYSTEM; IMMUNOREACTIVITY; NONHUMAN; RAT; RISK FACTOR; SHORT SURVEY; STEROIDOGENESIS; SYNOVIUM; SYSTEMIC LUPUS ERYTHEMATOSUS;

MURINAE;

EID: 0031944877     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-217-44251     Document Type: Short Survey

References (163)

1. Mick CC, Nicoll CS. Prolactin directly stimulates the liver in vivo to secrete a factor (synlactin) which acts synergistically with the hormone. Endocrinology 116:2049-2053, 1985.
2. Nicoll CS. Ontogeny and evolution of prolactin's functions. Fed Proc 39:2563-2566, 1980.
3. Shiu RP, Elsholtz HP, Tanaka T, Friesen HG, Gout PW, Beer CT, Noble RL. Receptor-mediated mitogenic action of prolactin in a rat lymphoma cell line. Endocrinology 113:159-165, 1983.
4. Russell DH, Matrisian L, Kibler R, Larson DF, Poulos B, Magun BE. Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochem Biophys Res Commun 121:899-906, 1984.
5. Russell DH, Kibler R, Matrisian L, Larson DF, Poulos B, Magun BE. Prolactin receptors on human T and B lymphocytes: Antagonism of prolactin binding by cyclosporine. J Immunol 134:3027-3031, 1985.
6. Berczi I, Nagy E. A possible role of prolactin in adjuvant arthritis. Arthritis Rheum 25:591-594, 1982.
7. Berczi I, Nagy E, Asa SL, Kovacs K. The influence of pituitary hormones on adjuvant arthritis. Arthritis Rheum 27:682-688, 1984.
8. Berczi I. The role of the growth and lactogenic hormone family in immune function. Neuroimmunomodulation 1:201-216, 1994.
9. Hooghe-Peters EL, Peters R. Growth Hormone, Prolactin and IGF-I as Lymphohemopoietic Cytokines. Austin, TX: RG Landes Co Publ, 1995.
10. Murphy WJ, Rui H, Longo DL. Effects of growth hormone and prolactin on immune development and function. Life Sci 57:1-14, 1995.
11. Wilder RL. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immun 13:307-338, 1995.
12. Neidhart M, Larson DF. Freund's complete adjuvant induced ornithine decarboxylase activity in the central nervous system of male rats and triggered the release of pituitary hormones. J Neuroimmun 26:97-105, 1990.
13. Ramachandra RN, Sehon AH, Berczi I. Neuro-hormonal host defense in endotoxin shock. Brain Behav Immun 6:157-169, 1992.
14. Neidhart M, Flückiger EW. Hyperprolactinemia in hypophysectomized or intact male rats and the development of adjuvant arthritis. Immunology 77:449-455, 1992.
15. Neidhart M. Bromocriptine microcapsules inhibit ornithine decarboxylase activity induced by Freund's complete adjuvant in lymphoid tissues of male rats. Endocrinology 125:2846-2852, 1989.
16. Neidhart M. Effects of Freund's complete adjuvant on the diurnal rhythms of neuroendocrine processes and ornithine decarboxylase activity in various tissues of male rats. Experientia 52:900-908, 1996.
17. Berczi I, Nagy E, Asa SL, Kovacs K. Pituitary hormones and contact sensitivity in rats. Allergy 38:325-330, 1983.
18. Nagy E, Berczi I, Friesen HG. Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol Copenh 102:351-357, 1983.
19. Berczi I, Nagy E, de Toledo SM, Matusik RJ, Friesen HG. Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue. J Immunol 146:2201-2206, 1991.
20. Esquifino AI, Villanua MA, Szary A, Yau J, Bartke A. Ectopic pituitary transplants restore immunocompetence in Ames dwarf mice. Acta Endocrinol Copenh 125:67-72, 1991.
21. Nagy E, Friesen HG, Sehon AH, Berczi I. Immunomodulation in rats by transplantable anterior pituitary tumors. Endocrinology 116:1117-1122, 1985.
22. Forni G, Bindoni M, Santoni A, Belluardo N, Marchese A, Giovarelli M. Radiofrequency destruction of the tuberoinfundibular region of the hypothalamus permanently abrogates NK cell activity in mice. Nature 306:181-184, 1983.
23. Mattsson R, Mattsson A, Hansson I, Holmdahl R, Rook GA, Whyte A. Increased levels of prolactin during, but not after, the immunisation with rat collagen II enhances the course of arthritis in DBA/1 mice. Autoimmunity 11:163-170, 1992.
24. Cincotta AH, Kinsley TL, Landry RJ, Miers WR, Gutierrez PJ, Esperanza P, Meieir AH. The immunoregulatory effects of prolactin in mice are time-of-day dependent. Endocrinology 136:2163-2171, 1995.
25. Gerli R, Rambotti P, Nicoletti I, Orlandi S, Migliorati G, Riccardi C. Reduced number of natural killer cells in patients with pathological hyperprolactinemia. Clin Exp Immunol 64:399-406, 1986.
26. Lavalle C, Loyo E, Paniagua R. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 14:268-272, 1987.
27. Folomeev M, Prokaeva T, Nassonova V. Prolactin levels in men with SLE and RA. J Rheumatol 17:1569-1570, 1991.
28. Buskila D, Sukenik S, Schoenfeld Y. The possible role of prolactin in autoimmunity. Am J Reprod Immunol 26:118-123, 1991.
29. Jara LJ, Graef A, Lavalle C. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J Rheumatol 18:349-353, 1991.
30. Jara LJ, Gomez-Sanchez C, Silveria LH, Martinez-Osuna P, Vasey FB, Espinoza LR. Hyperprolactinemia in systemic lupus erythematosus: Association with disease activity. Am J Med Sci 303:222-226, 1992.
31. McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: Possible hormonal stimulation of an autoimmune disease. J Rheumatol 21:843-850, 1994.
32. Neidhart M. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol 23:476-481, 1996.
33. El-Garf A, Salah S, Shaarawy M, Zaki S, Anwer S. Prolactin hormone in juvenile systemic lupus erythematosus: A possible relationship to disease activity and CNS manifestations. J Rheumatol 23:374-377, 1996.
34. McMurray R, Keisler D, Kanuckel K, Izui S, Walker SE. Prolactin influences autoimmune disease activity in the female B/W mouse. J Immunol 147:3780-3787, 1991.
35. McMurray R, Keisler D, Izui S, Walker SE. Hyperprolactinemia in male NZB/NZW (B/W) F1 mice: Accelerated autoimmune disease with normal circulating testosterone. Clin Immunol Immunopathol 71:338-343, 1994.
36. Petri M, Chan D, Magder L, Goldman D. Longitudinal analysis of prolactin and disease activity in SLE. Arthritis Rheum 38(Suppl):S220, 1995.
37. Silman A, Kay A, Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum 35:152-155, 1992.
38. Pauzner R, Urowitz MB, Gladman DD, Gough JM. Prolactin in systemic lupus erythematosus. J Rheumatol 21:2064-2067, 1994.
39. Ostendorf B, Fisher R, Santen R, Schmitz-Linneweber B, Specker C, Schneider M. Hyperprolactinemia in systemic lupus erythematosus? Scand J Rheumatol 25:97-102, 1996.
40. Maciel F, Cossermelli W, Gilberto J, Vieira H. Role of androgens and estrogens in systemic lupus erythematosus. Arthritis Rheum 39(Suppl):S251, 1996.
41. Buskila D, Lorber M, Neumann L, Flusser D, Shoenfeld Y. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol 23:629-632, 1996.
42. Stolte I, van den Hoogen F, Wijnands M, Sweep F, van de Putte L. Serum prolactin levels in patients with SLE and SLE-overlap syndrome. Arthritis Rheum 39(Suppl):S295, 1996.
43. Weiss-Carrington P. Secretory immunobiology of the mammary gland. In: Berczi I, Kovacs K, Eds. Hormones and Immunity. Lancaster, UK: MTP Press, pp 172-202, 1987.
44. McMurray R, Reissler D, Izui S, Walker SE. Effects of parturition, suckling, and pseudopregnancy on variable disease activity in the B/W mouse model of systemic lupus erythematosus. J Rheumatol 20:1143-1151, 1993.
45. Allen SH, Sharp GC, Wang G, Conley C, Takeda Y, Conroy SE, Walker SE. Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease. Lupus 5:30-37, 1996.
46. Moncayo R, Moncayo HE. A new endocrinological and immunological syndrome in SLE: Elevation of human chorionic gonadotropin and of antibodies directed against ovary and endometrium antigens. Lupus 4:39-45, 1995.
47. Buskila D, Berezin M, Gur H, Lin HC, Alosachie I, Terryberry JW, Barka N, Shen B, Peter JB, Shoenfeld Y. Autoantibody profile in the sera of women with hyperprolactinemia. J Autoimmun 8:415-424, 1995.
48. Houri M, Sharp GC, Wang G, Schlechte JA, Walker SE. High occurrence of positive fluorescent antinuclear antibody (FANA) tests and unique immunoblot patterns in hyperprolactinemic men. Arthritis Rheum 38 (Suppl):S172, 1995.
49. Gutierrez MA, Molina JF, Jara LJ, Garcia C, Gutierrez-Urena S, Cuellar ML, Gharavi A, Espinoza LR. Prolactin-induced immunoglobulin and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals. Int Arch Allergy Immunol 109:229-235, 1996.
50. Ferrari C, Boghen M, Paracchi A, Rampini P, Raiteri F, Benco R, Romussi M, Codecasa F, Mucci M, Bianco M. Thyroid autoimmunity in hyperprolactinemic disorders. Acta Endocrinol 104:35-41, 1983.
51. Kira J, Harada M, Yamaguchi Y, Shida N, Goto I. Hyperprolactinemia in multiple sclerosis. J Neurol Sci 102:61-66, 1991.
52. Halko G, Urrows S, Affleks G, Waterman J. Serum prolactin levels and disease activity in rheumatoid arthritis. Arthritis Rheum 38 (Suppl):S289, 1995.
53. Eulry F, Mayaudon H, Bauduceau B, Lechevalier D, Crozes P, Magnin J, Claude-Berthelot C. Blood prolactin under the effect of protirelin in spondyalarthropathies. Treatment trial of 4 cases of reactive arthritis and 2 cases of proriatic arthritis with bromocriptine. Ann Med Interne Paris 147:15-19, 1996.
54. Straub RH, Zeuner M, Lock G, Schölmerich J, Lang B. High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis. Br J Rheumatol 36:426-432, 1997.
55. Croxson TS, Chapman WE, Miller LK, Levit CD, Senie R, Zurnoff B. Changes in the hypothalamic-pituitary axis in human immunodeficiency virus-infected homosexual men. J Clin Endocrinol Metab 68:317-321, 1989.
56. Rzeszowska G, Jagiello-Wojtowicz E, Krawczuk G, Baran E, Bielec D, Fialka-Rymar M, Surmaczynska B. Level of prolactin, gonadotropin, testosterone, and alpha fetoprotein in serum or blood donors with antibodies to hepatitis C virus. Przegl Epidemiol 47:21-24, 1993.
57. Durant S, Alves V, Couland J, El Hasnaoui A, Dardenne M, Homo-Delarche F. Attempts to pharmacologically modulate prolactin levels and type 1 autoimmune diabetes in the nonobese diabetic (NOD) mouse. J Autoimmune 8:875-885, 1995.
58. Larson DF, Copeland JG, Russell DH. Prolactin predicts cardiac allograft rejection in cyclosporin immunosuppressed patients. Lancet 2:53, 1985.
59. Brennan P, Silman A. Breast-feeding and the onset of rheumatoid arthritis. Arthritis Rheum 37:808-813, 1994.
60. Jorgensen C, Picot MC, Bologna C, Sany J. Oral contraceptive, parity, breast feeding, and severity of rheumatoid arthritis. Ann Rheum Dis 55:94-98, 1996.
61. Rovensky J, Vigas M, Marek J, Blazickova S, Korcakova L, Vyletelkova L, Takac A. Evidence for immunomodulatory properties of prolactin in selected in vitro and in vivo situations. Int J Immunopharmacol 13:267-272, 1991.
62. Vera O, Jara LJ, Miranda JM, Fraga A. Elevated prolactin levels in women with silicone gel breast implants and with mineral mixed oil injections. Arthritis Rheum 38 (Suppl):S324, 1995.
63. Kawai T, Katoh K, Tani K. Hyperprolactinemia preceding development of autoimmune disease. J Rheumatol 23:1483-1484, 1996.
64. Stephanou A, Sarlis NJ, Knight RA, Lightman SL, Chowdrey HS. Glucocorticoid-mediated responses of plasma ACTH and anterior pituitary pro-opiomelanocortin, growth hormone and prolactin mRNA during adjuvant-induced arthritis in the rat. J Mol Endocrinol 9:273-281, 1992.
65. Spangelo BL, Judd AM, Isakson PC, MacLeod RM. Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinology 125:575-577, 1989.
66. Kennedy RL, Jones TH. Cytokines in endocrinology: Their roles in health and disease. Endocrinology 129:167-178, 1991.
67. Rettori V, Jurcovicova J, McCann SM. Central action of interleukin-1 in altering the release of TSH, growth hormone, and prolactin in the male rat. J Neurosci Res 18:179-183, 1987.
68. Harel G, Shamoun DS, Kane JP, Magner JA, Szabo M. Prolonged effects of tumor necrosis factor-alpha on anterior pituitary hormone release. Peptides 16:641-645, 1995.
69. Vankelecom H, Carmeliet P, Heremans H, Van Damme J, Dijkmans R, Billiau A, Denef C. Interferon-gamma inhibits stimulated adrenocorticotropin, prolactin, and growth hormone secretion in normal rat anterior pituitary cell cultures. Endocrinology 126:2919-2926, 1990.
70. Montgomery DW, LeFevre JA, Ulrich ED, Adamson CR, Zukoski CF. Identification of prolactin-like proteins synthesized by normal murine lymphocytes. Endocrinology 127:2601-260, 1990.
71. Shah GN, Laird HE II, Russell DH. Identification and characterization of a prolactin-like polypeptide synthesized by mitogen-stimulated murine lymphocytes. Int Immunol 3:297-304, 1991.
72. Gala RR, Shevach EM. Evidence for the release of a prolactin-like substance by mouse lymphocytes and macrophages. Proc Soc Exp Biol Med 205:12-19, 1994.
73. Gala RR, Rillema JA. Evaluation of prolactin-like activity produced by concanavalin-A stimulated mouse splenocytes. Life Sci 57:1683-1700, 1995.
74. Masten SA, Millard WJ, Karlix JL, Shiverick KT. Evaluation of immune parameters and lymphocyte production of prolactin-immunoreactive proteins after chronic administration of cocaine to pregnant rats. J Pharmacol Exp Ther 277:1090-1096, 1996.
75. Hiestand PC, Mekler P, Nordmann R, Grieder A, Permmongkol C. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc Natl Acad Sci USA 83:2599-2603, 1986.
76. Sabharwal P, Glaser R, Lafuse W, Varma S, Liu Q, Arkins S, Kooijman R, Kutz L, Kelley KW. Prolactin synthesized and secreted by human peripheral blood mononuclear cells: An autocrine growth factor for lymphoproliferation. Proc Natl Acad Sci USA 89:7713-7716, 1992.
77. Pellegrini I, Lebrun JJ, Ali S, Kelly PA. Expression of prolactin and its receptor in human lymphoid cells. Mol Cell Endocrinol 6:1023-1031, 1992.
78. O'Neal KD, Montgomery DW, Truong TM, Yu-Lee LY. Prolactin gene expression in human thymocytes. Mol Cell Endocrinol 87:RI9-R23, 1992.
79. Gutierrez MA, Molina JF, Jara LJ, Cuellar ML, Garcia C, Gutierrez-Urena S, Gharavi A, Espinoza LR. Prolactin and systemic lupus erythematosus: Prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity. Lupus 4:348-352, 1995.
80. Masten SA, Shiverik KT. Evidence that a mitogen inducible prolactin immunoreactive protein in rat spleen lymphocytes is aldolase A. Life Sci 60:2173-2182, 1997.
81. Nagy E, Berczi I. Pituitary dependence of bone marrow function. Br J Haematol 71:457-162, 1989.
82. Nagy E, Berczi I. Hypophysectomized rats depend on residual prolactin for survival. Endocrinology 128:2776-2784, 1991.
83. Dardenne M, Leite-de-Moraes MC, Kelly PA, Gagnerault MC. Prolactin receptor expression in human hematopoietic tissues analysed by flow cytofluorometry. Endocrinology 134:2108-2114, 1994.
84. Arkins S, Dantzer R, Kelley KW. Somatolactogens, somatomedins, and immunity. J Dairy Sci 76:2437-2450, 1993.
85. Bellone G, Geuna M, Carbone A, Silvestri S, Foa R, Emanuelli G, Matera L. Regulatory action of prolactin on the in vitro growth of CD34+ ve human hemopoietic progenitor cells. J Cell Physiol 163:221-231, 1995.
86. Dardenne M, Kelly PA, Bach JF, Savino W. Identification and functional activity of prolactin receptors in thymic epithelial cells. Proc Natl Acad Sci USA 88:9700-9704, 1991.
87. Nagano M, Kelly PA. Tissue distribution and regulation of rat prolactin receptor gene expression: Quantitative analysis by polymerase chain reaction. J Biol Chem 269:13337-13345, 1994.
88. Wu H, Devi R, Malarkey WB. Expression and localization of prolactin messenger ribonucleic acid in the human immune system. Endocrinology 137:349-353, 1996.
89. Spangelo BL, Hall NR, Dunn AJ, Goldstein AL. Thymosin fraction 5 stimulates the release of prolactin from cultured GH3 cells. Life Sci 40:283-288, 1987.
90. Spangelo BL, Judd AM, Ross PC, Login IS, Jarvis WD, Badamchian M, Goldstein AL, MacLeod RM. Thymosin fraction 5 stimulates prolactin and growth hormone release from anterior pituitary cells in vitro. Endocrinology 121:2035-2043, 1987.
91. Spangelo BL, Ross PC, Judd AM, MacLeod RM. Thymic stromal elements contain an anterior pituitary hormone-stimulating activity. J Neuroimmunol 25:37-46, 1989.
92. Badamchian M, Spangelo BL, Damavandy T, MacLeod RM, Goldstein AL. Complete amino acid sequence analysis of a peptide isolated from the thymus that enhances release of growth hormone and prolactin. Endocrinology 128:1580-1588, 1991.
93. Cocchi D, Bardone MR, Moretti R, Travaglini P. Effect of thymomodulin on luteinizing hormone, prolactin, and testosterone in male rats. Thymus 19:53-58, 1992.
94. Gagnerault MC, Touraine P, Savino W, Kelly PA, Dardenne M. Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol 150:5673-5681, 1993.
95. Leite-de-Moraes MC, Touraine P, Gagnerault MC, Savino W, Kelly PA, Dardenne M. Prolactin receptors and the immune system. Ann Endocrinol Paris 56:567-570, 1995.
96. Gaufo GO, Diamond MC. Prolactin increases CD4/CD8 cell ratio in thymus-grafted congenitally athymic nude mice. Proc Natl Acad Sci USA 30:4165-4169, 1996.
97. Gala RR, Shevach EM. Identification by analytical flow cytometry of prolactin receptors on immunocompetent cell populations in the mouse. Endocrinology 133:1617-1623, 1993.
98. Viselli SM, Mastro AM. Prolactin receptors are found on heterogenous subpopulations of rat splenocytes. Endocrinology 132:571-576, 1993.
99. Koh CY, Phillips JT. Prolactin receptor expression by lymphoid tissues in normal and immunized rats. Mol Cell Endocrinol 92:R21-R25, 1993.
100. Gunes H, Mastro AM. Prolactin receptor gene expression in rat splenocytes and thymocytes from birth to adulthood. Mol Cell Endocrinol 117:41-52, 1996.
101. Zerek-Melen G, Winczyk K, Kunert-Radek J, Pawlikowski M. Effects of metoclopramide on rat spleen lymphocyte proliferation. Biochem Biophys Res Commun 171:1099-1104, 1990.
102. Viselli SM, Stanek EM, Mukherjee P, Hymer WC, Mastro AM. Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats. Endocrinology 129:983-990, 1991.
103. Russell DH, Larson DF, Cardon SB, Copeland JG. Cyclosporine inhibits prolactin induction of ornithine decarboxylase in rat tissues. Mol Cell Endocrinol 35:159-166, 1984.
104. Bernton E, Meltzer MS, Holaday JW. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 239:401-407, 1988.
105. Edwards CK III, Schepper JM, Yunger LM, Kelley KW. Somatotropin and prolactin enhance respiratory burst activity of macrophages. Ann NY Acad Sci 540:698-703, 1988.
106. Edwards CK III, Ghiasuddin SM, Yunger LM, Lorence RM, Arkins S, Dantzer R, Kelley KW. In vivo administration of recombinant growth hormone or gamma interferon on activities of macrophages: Enhanced resistance to experimental Salmonella typhimurium infection is correlated with generation of reactive oxygen intermediates. Infect Immun 60:2514-2521, 1992.
107. Chen Y, Johnson AG. In vivo activation of macrophages by prolactin from young and aging mice. Int J Immunopharmacol 15:39-45, 1993.
108. Gaytan F, Romero JL, Belido C, Morales C, Reymundo C, Aguilar E. Effects of growth hormone and prolactin on testicular macrophages in long-term hypophysectomized rats. J Reprod Immunol 27:73-84, 1994.
109. Fu YK, Arkins S, Fuh G, Cunningham BC, Wells JA, Fong S, Cronin MJ, Dantzer R, Kelley KW. Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor. J Clin Invest 89:451-457, 1992.
110. Murphy WJ, Durum SK, Longo DL. Differential effects of growth hormone and prolactin on murine T-cell development and function. J Exp Med 178:231-236, 1993.
111. Giglio T, Imro MA, Filaci G, Scudeletti M, Puppo F, De Cecco L, Indiveri F, Costantini S. Immune cell circulating subsets are affected by gonadal function. Life Sci 54:1305-1312, 1994.
112. Neidhart M. The serum levels of interleukin-1β, luteinizing hormone and prolactin correlate with the expression of CD45 isoforms on CD4+ peripheral blood T lymphocytes in healthy women. Ann Hematol 75:155-160, 1997.
113. Maes M, Bosmans E, Meltzer HY. Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol. Eur Arch Psychiatry Clin Neurosci 245:172-178, 1995.
114. Chakraborty A, Chakraborty NG, Chattopadhyay U. Prolactin response of NK cells, but not LAK cells, is deficient in patients with carcinoma of oral cavity and during aging. Int J Cancer 66:65-69, 1996.
115. Yu-Lee LY. Prolactin stimulates transcription of growth-related genes in Nb2 T-lymphoma cells. Mol Cell Endocrinol 68:21-28, 1990.
116. Clevenger CV, Ngo W, Sokol DL, Luger SM, Gewirtz AM. Vav is necessary for prolactin-stimulated proliferation and is translocated into the nucleus of a T-cell line. J Biol Chem 270:13246-13253, 1995.
117. Rao Y, Buckley DJ, Buckley AR. Rapid activation of mitogen-activated protein kinase and p21ras by prolactin and interleukin 2 in rat Nb2 node lymphoma cells. Cell Growth Differ 6:1235-1244, 1995.
118. Spangelo BL, Hall NR, Ross PC, Goldstein AL. Stimulation of in vivo antibody production and concanavalin-A-induced mouse spleen cell mitogenesis by prolactin. Immunopharmacology 14:11-20, 1987.
119. Clevenger CV, Sillman AL, Hanley-Hide J, Rystowsky MB. Requirement for prolactin during cell cycle regulated gene expression in cloned T lymphocytes. Endocrinology 130:3216-3222, 1992.
120. Athreya BH, Pletcher J, Zulian F, Weiner DB, Williams WV. Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro. Clin Immunol Immunopathol 66:201-211, 1993.
121. Lahat N, Miller A, Shtiller R, Touby E. Differential effects of prolactin upon activation and differentiation of human B-lymphocytes. J Neuroimmunol 47:35-40, 1993.
122. Cesario TC, Yousefi S, Carandang G, Sadati N, Le J, Vaziri N. Enhanced yields of gamma interferon in prolactin-treated human peripheral blood mononuclear cells. Proc Soc Exp Biol Med 205:89-95, 1994.
123. Stevens AM, Lee LY. Multiple prolactin-responsive elements mediate G1 and S phase expression of the interferon regulatory factor-1 gene. Mol Endocrinol 8:345-355, 1994.
124. Rovensky J, Buc M, Lojda Z, Ruzickova M, Blazickova S, Rauova L, Mistina T, Vigas M, Lackovic V. Effect of domperidone-induced hyperprolactinemia on selected immune parameters in healthy women. Arch Immunol Ther Exp Warsz 43:221-227, 1995.
125. Galdiero M, Donnarumma G, Cipollaro de l'Ero G, Marcatili A, Scarfogliero P, Sommese L. Effect of growth hormone, prolactin, and insulin on the release of IL-1-alpha, INF-gamma and IL-4 by staphylococcal enterotoxin A-stimulated splenocytes. Eur Cytokine Netw 6:187-194, 1995.
126. Vitiello M, Scarfogliero P, Galdiero M, Gorga F, Sommese L. Prolactin and insulin regulate the release of IL-1-alpha and INF-gamma from murine splenocytes activated with porins or LPS of Salmonella typhimurium. Immunol Cell Biol 73:452-456, 1995.
127. Clevenger CV, Russell DII, Appasamy PM, Prystowsky MB. Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin. Proc Natl Acad Sci USA 87:6460-6464, 1990.
128. Cesano A, Oberholtzer E, Contarini M, Contarini M, Geuna M, Bellone G, Matera L. Independent and synergistic effect of interleukin-2 and prolactin on development of T- and NK-derived LAK effectors. Immunopharmacology 28:67-75, 1994.
129. Prystowsky MB, Clevenger CV. Prolactin as a second messenger for interleukin 2. Immunomethods 5:49-55, 1994.
130. Tsai SC, Heppner GH. Immunoendocrine mechanisms in mammary tumor progression: Direct prolactin modulation of peripheral and preneoplastic hyperplastic-alveolar-nodule-infiltrating lymphocytes. Cancer Immunol Immunother 39:291-298, 1994.
131. Gala RR, Shevach EM. The immunomodulatory effects of a recombinant bovine prolactin are secondary to endotoxin contamination. FASEB J 11:A99 (abstract), 1997.
132. Zhu XH, Zellweger R, Ayala A, Chaudry JH. Prolactin inhibits the increased cytokine gene expression in Kupffer cells following haemorrhage. Cytokine 8:134-140, 1996.
133. Benedetto N, Folgore A, Galdiero M, Meli R, DiCarlo R. Effect of prolactin, rINF-gamma or rTNF-alpha in murine toxoplasmosis. Pathol Biol Paris 43:395-400, 1995.
134. Gala RR, Shevach EM, Influence of prolactin and growth hormone on the activation of dwarf mouse lymphocytes in vivo. Proc Soc Exp Biol Med 204:224-230, 1993.
135. Gilmour KC, Pine R, Reich NC. Interleukin-2 activates STATS transcription factor (mammary gland factor) and specific gene expression in T lymphocytes. Proc Natl Acad Sci USA 92:10772-10776, 1995.
136. Gouilleux F, Moritz D, Humar M, Moriggi R, Bechtold S, Groner B. Prolactin and interleukin-2 receptors in T-Iymphocytes signal through an MGF-STAT5-like transcription factor. Endocrinology 136:5700-5708, 1995.
137. Gala RR. Influence of thyroxine and thyroxine with growth hormone and prolactin on splenocyte subsets and on the expression of interleukin-2 and prolactin receptors on splenocyte subsets of Snell dwarf mice. Proc Soc Exp Biol Med 210:117-125, 1995.
138. Hawkins TA, Gala RR, Dunbar JC. The lymphocyte and macrophage profile in the pancreas and spleen of NOD mice: Percentage of interleukin-2 and prolactin receptors on immunocompetent cell subsets. Autoimmunity 18:155-162, 1994.
139. Palestine AG, Muellenberg-Coulombre CG, Kim MK, Gelato MC, Nussenblatt RB. Bromocriptine and low-dose cyclosporine A, D, and G in the treatment of experimental uveitis in rats. J Immunopharmacol 8:427-435, 1987.
140. Neidhart M. Synergism between long-acting bromocryptine microcapsules and cyclosporine A in the prevention of various autoimmune diseases in rats. Experientia 52:892-899, 1996.
141. Neidhart M. Bromocriptine has little direct effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion. Biomed Pharmacother 51:118-125, 1997.
142. McMurray RW, Weidensaul D, Allen SH, Walker SE. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol 22:2084-2091, 1995.
143. Anisman H, Baines MG, Berczi I, Bernstein CN, Biennerhassett MG, Gorczynski RM, Greenberg AH, Kisil FT, Mathison RD, Nagy E, Nance DM, Perdue MH, Pomerantz DK, Sabbadini ER, Stanisz A, Warrington RJ. Neuroimmune mechanisms in health and disease: 1. Health. Can Med Assoc J 155:867-874, 1996.
144. Anisman H, Baines MG, Berczi I, Bernstein CN, Biennerhassett MG, Gorczynski RM, Greenberg AH, Kisil FT, Mathison RD, Nagy E, Nance DM, Perdue MH, Pomerantz DK, Sabbadini ER, Stanisz A, Warrington RJ. Neuroimmune mechanisms in health and disease: 2. Disease. Can Med Assoc J 155:1075-1082, 1996.
145. Jorgensen C, Sany J. Modulation of the immune response by the neuro-endocrine axis in rheumatoid arthritis. Clin Exp Rheumatol 12:435-141, 1994.
146. Curti BD, Urba WJ, Longo DL, Janik JE, Sharman WH, Miller LL, Cizza G, Shimizu M, Oppenheim JJ, Alvord WG, Smith JW. Endocrine effects of IL-1 alpha and beta administered in a phase-I trial to patients with advanced cancer. J Immunother Emphasis Tumor Immunol 19:142-148, 1996.
147. Purcell ES, Wood GW, Gattone VH. Immune system of the spontaneously hypertensive rat: II. Morphology and function. Anat Rec 237:236-242, 1993.
148. Whyte A, Williams RO. Bromocriptine suppresses postpartum exacerbation of collagen-induced arthritis. Arthritis Rheum 31:927-928, 1988.
149. Mattsson R, Mattson A, Holmdahl R, Whyte A, Rook GA. Maintained pregnancy levels of oestrogen afford complete protection from postpartum exacerbation of collagen-induced arthritis. Clin Exp Immunol 85:41-47, 1991.
150. Chikanza IC, Petrou P, Chrousos G, Kingsley G, Panayi GS. Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: Immunopathogenetic and therapeutic implications. Br J Rheumatol 32:445-448, 1993.
151. Zautra AJ, Burleson MH, Matt KS, Roth S, Burrows L. Interpersonal stress, depression, and disease activity in rheumatoid arthritis and osteoarthritis patients. Health Psychol 13:139-148, 1994.
152. Prokaeva TB, Alekberova ZS, Folomeev M, Mataradze GD. Clinical characteristic of disorders of sexual functions in patients with rheumatoid arthritis. Revmatologiia Mosk Jan-Mar, 18-22, 1991.
153. Brennan P, Ollier B, Worthington J, Hajeer A, Silman A. Are both genetic and reproductive associations with rheumatoid arthritis linked to prolactin? Lancet 348:106-109, 1996.
154. Jorgensen C, Bressot N, Bologna C, Sany J. Dysregulation of the hypothalamo-pituilary axis in rheumatoid arthritis. J Rheumatol 22:1829-1833, 1995.
155. Jorgensen C, Maziat H, Bologna C, Sany J. Kinetics of prolactin release in rheumatoid arthritis. Clin Exp Rheumatol 13:705-709, 1995.
156. Brennan P, Hajeer A, Ren Ong K, Worthington J, John S, Thompson W, Silman A, Ollier B. Allelic markers close to prolactin are associated with HLA-DRB1 susceptibility alleles among women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 40:1383-1386, 1997.
157. Richards RG, Hartman SM. Human dermal fibroblast cells express prolactin in vitro. J Invest Dermatol 106:1250-1255, 1996.
158. Bazan JF. Structural design and molecular evolution of a cytokine receptor family. Proc Natl Acad Sci USA 87:6934-6938, 1990.
159. Hedman M, Nilsson E, de la Torre B. Low blood and synovial fluid levels of sulpho-conjugated steroids in rheumatoid arthritis. Clin Exp Rheumatol 10:25-30, 1992.
160. Jikihara H, Handwerger S. Tumor necrosis factor-alpha inhibits the synthesis and release of human decidual prolactin. Endocrinology 134:353-357, 1994.
161. Misery L, Claudy A. Interactions of neuromediators and neurohormones on dendritic cells, monocytes and macrophages (out of the central nervous system). Pathol Biol Paris 43:876-881, 1995.
162. Ijaz MK, Dent D, Babiuk LA. Neuroimmunomodulation of in vivo anti-rotavirus humoral response. J Neuroimmunol 26:159-171, 1990.
163. Mok CC, Lau CS. Lack of association between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol 23:2185-2186, 1996.